| Abstrakt: |
A recent study conducted at Hasbro Children's Hospital in Providence, Rhode Island, has reported on the evaluation and management of methimazole-induced agranulocytosis in pediatric patients with thyrotoxicosis. Agranulocytosis is a rare but serious complication of methimazole use for Graves' disease, and treatment requires discontinuation of methimazole. The study found that prolonged use of saturated solution of potassium iodide (SSKI) was effective in managing thyrotoxicosis in a 17-year-old female patient with methimazole-induced agranulocytosis. The research also highlighted the importance of subspecialty input and intensive evaluation and monitoring in managing agranulocytosis and its associated sequelae. [Extracted from the article] |
